CATHY CARRON: Open Payments
NPI 1043256290 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 25 payments from 5 companies in 2025. Trend: 2023 $272 · 2024 $600 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $212 |
| Lilly USA, LLC | 10 | $135 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Novo Nordisk Inc | 2 | $43 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
Products named: MOUNJARO, BREZTRI, VOQUEZNA, Ozempic.
Industry payments across NY — which companies pay providers there.
